Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Bronchodilator and anti-inflammatory therapies are still the mainstays of pharmacological treatment in Chronic obstructive pulmonary disease (COPD) / Emphysema
2021 Global strategy for prevention, diagnosis and management of COPD. https://goldcopd.org/2021-gold-reports/.
Long-term oxygen therapy improves survival in patients with chronic obstructive pulmonary disease (COPD) and chronic severe daytime hypoxemia.
There are few effective therapies, and none of the treatments currently available prevent the progression of the disease or target all of the hallmar…